PMDA — authorised 1 July 2011
- Marketing authorisation holder: Nippon Boehringer Ingelheim Co., Ltd
- Status: approved
🇯🇵 Tradjenta in Japan
PMDA authorised Tradjenta on 1 July 2011
Marketing authorisation
Tradjenta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Japan
Frequently asked questions
Is Tradjenta approved in Japan?
Yes. PMDA authorised it on 1 July 2011.
Who is the marketing authorisation holder for Tradjenta in Japan?
Nippon Boehringer Ingelheim Co., Ltd holds the Japanese marketing authorisation.